Current Indications for Transcatheter Mitral Valve Replacement Using Transcatheter Aortic Valves

Use of transcatheter mitral valve replacement (TMVR) using aortic valves in clinical practice is limited to patients with failing bioprostheses and rings or disease associated severe annulus calcification. Whereas the use valve-in-valve TMVR appears be a reasonable alternative surgery at high surgical risk, much less evidence supports valve-in-ring valve-in-mitral calcification interventions. Data on results these settings are derived from small case series voluntary registries. This review summarizes current characteristics candidates, screening process, performance procedure, description future perspectives. dedicated devices native noncalcified diseases beyond scope article.